Rallybio & Candid Merger: $50M Breakup Fee, $700M Cash
Hartford News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Rallybio and Candid Therapeutics merge, with Candid potentially paying a $50 million breakup fee. The combined company, keeping the Candid Therapeutics name, will have a $700 million cash runway, set to close in mid-2026, pending approvals.
Support the show
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected]
View sources & latest updates
https://sources.thednn.ai/1823ca40eb2e549f